Inari Medical (NASDAQ:NARI) Rating Lowered to Neutral at Piper Sandler
Piper Sandler downgraded shares of Inari Medical (NASDAQ:NARI – Free Report) from an overweight rating to a neutral rating in a report published on Thursday morning, MarketBeat.com reports. Piper Sandler currently has $55.00 target price on the stock, down from their prior target price of $85.00. Other equities research analysts also recently issued reports about […]
More Stories
Netflix’s Upcoming Adult Animated Series, Dang! Release Date, Trailer, Plot, and More
Are you ready to meet the most chaotic siblings on Netflix? The upcoming adult animated series, Dang!, is coming soon....
US Business Activity Hits 52-Month High in August: S&P Global
By Andrew Moran Business activity kicked into high gear this month, accelerating at its fastest pace in more than four...
US Imposes Sanctions on Hezbollah Cash Smuggling Ring
By Timothy Frudd The Treasury Department announced sanctions on Aug. 20 against 10 individuals accused of running a cash smuggling...
900 Visas Revoked in Birth Tourism Crackdown: State Department
By Jack Phillips The U.S. Department of State on Aug. 20 said that nearly 900 visas have been revoked since...
A Man on the Inside: Release Date, Trailer, Plot, and Episode Updates
Is your favourite detective, Ted Danson, returning with a season 3 of A Man on the Inside? Fans are looking...
8 Killed After Charter Plane Crashes in Western Alaska: US Military
By AldgraFredly The U.S. military said on Aug. 20 that eight people were killed after a charter plane crashed at...